1. Homepage
  2. Equities
  3. Canada
  4. Toronto Stock Exchange
  5. KP Tissue Inc.
  6. News
  7. Summary
    KPT   CA48265Y1043

KP TISSUE INC.

(KPT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

KP Tissue Says New Sherbrooke Plant Doubled its Tissue Paper Capacity

12/17/2021 | 08:28am EDT


© MT Newswires 2021
Stocks mentioned in the article
ChangeLast1st jan.
KP TISSUE INC. 1.13% 10.75 Delayed Quote.3.27%
LDC 3.99% 93.8 Real-time Quote.-3.10%
All news about KP TISSUE INC.
05/12TRANSCRIPT : KP Tissue Inc., Q1 2022 Earnings Call, May 12, 2022
CI
05/12KP Tissue Declares A Quarterly Dividend, Payable on July 15, 2022
CI
05/12KP Tissue declares a Quarterly Dividend of $0.18 per Common Share
GL
05/12KP Tissue declares a Quarterly Dividend of $0.18 per Common Share
AQ
05/12KP Tissue Releases First Quarter 2022 Financial Results
GL
05/12KP Tissue Releases First Quarter 2022 Financial Results
AQ
05/12KP Tissue Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
05/11REPEAT - KP Tissue to Release its Financial Results and those of Kruger Products L.P. f..
GL
05/11REPEAT - KP Tissue to Release its Financial Results and those of Kruger Products L.P. f..
GL
04/12KP Tissue to Release its Financial Results and those of Kruger Products L.P. for the Fi..
GL
More news
Analyst Recommendations on KP TISSUE INC.
More recommendations
Financials
Sales 2022 1 733 M 1 360 M 1 360 M
Net income 2022 11,9 M 9,34 M 9,34 M
Net Debt 2022 957 M 751 M 751 M
P/E ratio 2022 63,2x
Yield 2022 6,70%
Capitalization 107 M 83,8 M 83,8 M
EV / Sales 2022 0,61x
EV / Sales 2023 0,65x
Nbr of Employees 2 700
Free-Float 99,9%
Chart KP TISSUE INC.
Duration : Period :
KP Tissue Inc. Technical Analysis Chart | KPT | CA48265Y1043 | MarketScreener
Technical analysis trends KP TISSUE INC.
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 6
Last Close Price 10,75 CAD
Average target price 10,92 CAD
Spread / Average Target 1,55%
EPS Revisions
Managers and Directors
Dino J. Bianco Chief Executive Officer
Mark Holbrook Chief Financial Officer
François Vimard Chairman
Michel Letellier Independent Director
James Hardy Independent Director
Sector and Competitors